Hwail Pharmaceutical Co.,Ltd.

₩5,390As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:061250Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (13.20%)
Div yield 6.18%
ROE 1.94%
Pharmaceutical Preparations
Beta (5Y) 0.18
PE TTM 11.36
TSR TTM (51.22%)
Mkt cap ₩45.35B
ROIC 1.74%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩6,883
27.71%
(71.29%)
Hold 7|5|6|5|3
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
106.85
117.48
115.69
114.93
9.53%
9.93%
3.13%
3.46%
Revenue₩B
2.090
2.027
1.992
2.110
4.33%
(4.40%)
(7.29%)
0.16%
Peers (US$33.44M)
Cap (US$)
PE
33.23M
6.691x
33.17M
—
31.33M
11.57x
Capital
TTM
5Y
10Y
Leveragex
2.636
(0.021)
(0.016)
EBIT/Intx
1.116
0.140
0.177
Own earn%
(149.18)
17.00
14.73
Sh yield%
27.85
22.70
22.79
Owners
Insiders/Inst%
11.72
58.10
Short interest%
1.30
SBC / revenue%
4.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
12–17
$1 testx
—
Incr. ROIC%
3